Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma.

Jackson S, Patay Z, Howarth R, Pai Panandiker AS, Onar-Thomas A, Gajjar A, Broniscer A.

J Neurooncol. 2013 Sep;114(3):339-44. doi: 10.1007/s11060-013-1189-0. Epub 2013 Jun 29.

2.

Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.

Porkholm M, Valanne L, Lönnqvist T, Holm S, Lannering B, Riikonen P, Wojcik D, Sehested A, Clausen N, Harila-Saari A, Schomerus E, Thorarinsdottir HK, Lähteenmäki P, Arola M, Thomassen H, Saarinen-Pihkala UM, Kivivuori SM.

Pediatr Blood Cancer. 2014 Sep;61(9):1603-9. doi: 10.1002/pbc.25045. Epub 2014 Apr 1.

PMID:
24692119
3.

Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.

Janssens GO, Gandola L, Bolle S, Mandeville H, Ramos-Albiac M, van Beek K, Benghiat H, Hoeben B, Morales La Madrid A, Kortmann RD, Hargrave D, Menten J, Pecori E, Biassoni V, von Bueren AO, van Vuurden DG, Massimino M, Sturm D, Peters M, Kramm CM.

Eur J Cancer. 2017 Mar;73:38-47. doi: 10.1016/j.ejca.2016.12.007. Epub 2017 Feb 3.

PMID:
28161497
4.

Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).

Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, Fisher D, Kearns P, Picton S, Saran F, Gibson M, Glaser A, Connolly DJ, Hargrave D.

Eur J Cancer. 2013 Dec;49(18):3856-62. doi: 10.1016/j.ejca.2013.08.006. Epub 2013 Sep 4.

5.

Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.

Klimo P Jr, Nesvick CL, Broniscer A, Orr BA, Choudhri AF.

J Neurosurg Pediatr. 2016 Jan;17(1):57-65. doi: 10.3171/2015.6.PEDS15166. Epub 2015 Oct 16.

PMID:
26474099
6.

Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma.

Bartels U, Wolff J, Gore L, Dunkel I, Gilheeney S, Allen J, Goldman S, Yalon M, Packer RJ, Korones DN, Smith A, Cohen K, Kuttesch J, Strother D, Baruchel S, Gammon J, Kowalski M, Bouffet E.

Neuro Oncol. 2014 Nov;16(11):1554-9. doi: 10.1093/neuonc/nou091. Epub 2014 May 20.

7.

Pediatric diffuse intrinsic pontine glioma patients from a single center.

Kebudi R, Cakir FB, Agaoglu FY, Gorgun O, Ayan I, Darendeliler E.

Childs Nerv Syst. 2013 Apr;29(4):583-8. doi: 10.1007/s00381-012-1986-3. Epub 2012 Dec 8.

PMID:
23224361
8.

Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.

Zaky W, Wellner M, Brown RJ, Blüml S, Finlay JL, Dhall G.

Pediatr Hematol Oncol. 2013 Oct;30(7):623-32. doi: 10.3109/08880018.2013.829895.

PMID:
24050762
9.

Young age may predict a better outcome for children with diffuse pontine glioma.

Broniscer A, Laningham FH, Sanders RP, Kun LE, Ellison DW, Gajjar A.

Cancer. 2008 Aug 1;113(3):566-72. doi: 10.1002/cncr.23584.

10.

Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.

Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS, Reddingius R, Peeters CM, Schouten-van Meeteren AY, Gooskens RH, Granzen B, Paardekooper GM, Janssens GO, Noske DP, Barkhof F, Kramm CM, Vandertop WP, Kaspers GJ, van Vuurden DG.

Neuro Oncol. 2015 Jan;17(1):160-6. doi: 10.1093/neuonc/nou104. Epub 2014 Jun 5.

11.

Diffuse intrinsic pontine glioma biopsy: a single institution experience.

Wang ZJ, Rao L, Bhambhani K, Miller K, Poulik J, Altinok D, Sood S.

Pediatr Blood Cancer. 2015 Jan;62(1):163-5. doi: 10.1002/pbc.25224. Epub 2014 Sep 27.

12.

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, DeWire M.

J Neurooncol. 2016 Mar;127(1):53-61. doi: 10.1007/s11060-015-2008-6. Epub 2015 Dec 1.

PMID:
26626490
13.

Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma.

Pai Panandiker AS, Wong JK, Nedelka MA, Wu S, Gajjar A, Broniscer A.

Pediatr Blood Cancer. 2014 Jul;61(7):1180-3. doi: 10.1002/pbc.24971. Epub 2014 Jan 30.

14.

Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Yamasaki F, Kurisu K, Kajiwara Y, Watanabe Y, Takayasu T, Akiyama Y, Saito T, Hanaya R, Sugiyama K.

Neuro Oncol. 2011 Jul;13(7):791-801. doi: 10.1093/neuonc/nor038. Epub 2011 Jun 8.

15.

Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.

Gokce-Samar Z, Beuriat PA, Faure-Conter C, Carrie C, Chabaud S, Claude L, Di Rocco F, Mottolese C, Szathmari A, Chabert C, Frappaz D.

Childs Nerv Syst. 2016 Aug;32(8):1415-23. doi: 10.1007/s00381-016-3153-8. Epub 2016 Jul 5.

PMID:
27379495
16.

Radiation and subsequent reirradiation outcomes in the treatment of diffuse intrinsic pontine glioma and a systematic review of the reirradiation literature.

Freese C, Takiar V, Fouladi M, DeWire M, Breneman J, Pater L.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):86-92. doi: 10.1016/j.prro.2016.11.005. Epub 2016 Nov 23. Review.

PMID:
28274399
17.

Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.

Kaye EC, Baker JN, Broniscer A.

CNS Oncol. 2014 Nov;3(6):421-31. doi: 10.2217/cns.14.47. Review.

PMID:
25438813
18.

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.

Veldhuijzen van Zanten SE, Jansen MH, Sanchez Aliaga E, van Vuurden DG, Vandertop WP, Kaspers GJ.

Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64. doi: 10.1586/14737140.2015.974563. Epub 2014 Nov 29.

PMID:
25435089
19.

Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.

Veldhuijzen van Zanten SE, van Meerwijk CL, Jansen MH, Twisk JW, Anderson AK, Coombes L, Breen M, Hargrave OJ, Hemsley J, Craig F, Cruz O, Kaspers GJ, van Vuurden DG, Hargrave DR; SIOPE DIPG Network.

Neuro Oncol. 2016 Apr;18(4):582-8. doi: 10.1093/neuonc/nov250. Epub 2015 Oct 11.

20.

Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.

Aguilera DG, Mazewski C, Hayes L, Jordan C, Esiashivilli N, Janns A, Macdonald TJ.

J Pediatr Hematol Oncol. 2013 Jan;35(1):e42-6. doi: 10.1097/MPH.0b013e318279aed8.

PMID:
23249962

Supplemental Content

Support Center